Joshua Reed Aldeyra Therapeutics, Inc. (ALDX) insider trading activity

ALDX Quotes by TradingView

Joshua Reed is Chief Financial Officer of Aldeyra Therapeutics, Inc.. Currently has a direct ownership of 274,825 shares of ALDX, which is worth approximately $876,691. The most recent transaction as insider was on Mar 30, 2022, when has been sold 93,322 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 275K
0% 3M change
0% 12M change
Total Value Held $876,691

Joshua Reed Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 30 2022
BUY
Grant, award, or other acquisition
-
93,322 Added 25.35%
274,825 Common Stock

Also insider at

SRRK
Scholar Rock Holding Corp Healthcare
OMGA
Omega Therapeutics, Inc. Healthcare
Chief Financial Officer
JR

Joshua Reed

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on ALDX

Follow Aldeyra Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALDX shares.

Notify only if

Insider Trading

Get notified when an Aldeyra Therapeutics, Inc. insider buys or sells ALDX shares.

Notify only if

News

Receive news related to Aldeyra Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALDX